Sera Prognostics (SERA) Interest Coverage Ratio Growth (3y) (2023 - 2026)
Sera Prognostics (SERA) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | -35.05% |
| 10 | Sera Prognostics | 103.03 Mn | 103.03 Mn | -28,000.00 | 79.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.45% |
| Dec 31, 2025 | -149.17% |
| Sep 30, 2025 | 83.48% |
| Jun 30, 2025 | 66.34% |
| Mar 31, 2025 | 11.89% |
| Dec 31, 2024 | 86.60% |
| Sep 30, 2024 | -36.50% |
| Jun 30, 2024 | -26.32% |
| Mar 31, 2024 | -128.32% |
| Dec 31, 2023 | 65.00% |
| Sep 30, 2023 | -68.34% |
| Jun 30, 2023 | -331.44% |